Cargando…
T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
Pancreatic disorders cause a broad spectrum of clinical diseases, mainly including acute and chronic pancreatitis and pancreatic cancer, and are associated with high global rates of morbidity and mortality. Unfortunately, the pathogenesis of pancreatic disease remains obscure, and there is a lack of...
Autores principales: | Zhou, Qi, Tao, Xufeng, Xia, Shilin, Guo, Fangyue, Pan, Chen, Xiang, Hong, Shang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105736/ https://www.ncbi.nlm.nih.gov/pubmed/32266154 http://dx.doi.org/10.3389/fonc.2020.00382 |
Ejemplares similares
-
Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation
por: Xiang, Hong, et al.
Publicado: (2021) -
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives
por: Wu, Yu, et al.
Publicado: (2021) -
Targeting MicroRNA Function in Acute Pancreatitis
por: Xiang, Hong, et al.
Publicado: (2017) -
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021) -
Bacterial community mapping of the intestinal tract in acute pancreatitis rats based on 16S rDNA gene sequence analysis
por: Tao, Xufeng, et al.
Publicado: (2019)